1 Wen, P. Y. & Kesari, S. Malignant gliomas in adults. N Engl J Med 359, 492-507, doi:10.1056/NEJMra0708126 (2008).
2 Tanaka, S., Louis, D. N., Curry, W. T., Batchelor, T. T. & Dietrich, J. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat Rev Clin Oncol 10, 14-26, doi:10.1038/nrclinonc.2012.204 (2013).
3 Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396-401, doi:10.1038/nature03128 (2004).
4 Koch, L. Functional genomics: Screening for lncRNA function. Nat Rev Genet 18, 70, doi:10.1038/nrg.2016.168 (2017).
5 Ma, L., Bajic, V. B. & Zhang, Z. On the classification of long non-coding RNAs. RNA Biol 10, 925-933, doi:10.4161/rna.24604 (2013).
6 Mercer, T. R., Dinger, M. E. & Mattick, J. S. Long non-coding RNAs: insights into functions. Nat Rev Genet 10, 155-159, doi:10.1038/nrg2521 (2009).
7 Naidu, S. & Garofalo, M. microRNAs: An Emerging Paradigm in Lung Cancer Chemoresistance. Front Med (Lausanne) 2, 77, doi:10.3389/fmed.2015.00077 (2015).
8 Patel, J. S. et al. Non-coding RNA as mediators in microenvironment-breast cancer cell communication. Cancer Lett 380, 289-295, doi:10.1016/j.canlet.2015.11.016 (2016).
9 Bian, E. B. et al. LncRNAs: new players in gliomas, with special emphasis on the interaction of lncRNAs With EZH2. J Cell Physiol 230, 496-503, doi:10.1002/jcp.24549 (2015).
10 Zhang, X. Q. & Leung, G. K. Long non-coding RNAs in glioma: functional roles and clinical perspectives. Neurochem Int 77, 78-85, doi:10.1016/j.neuint.2014.05.008 (2014).
11 Wang, Q. et al. A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma. Cancer Lett 373, 251-259, doi:10.1016/j.canlet.2016.01.039 (2016).
12 Jing, S. Y. et al. Expression of long non-coding RNA CRNDE in glioma and its correlation with tumor progression and patient survival. Eur Rev Med Pharmacol Sci 20, 3992-3996 (2016).
13 Shi, D. et al. A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma. Oncotarget 8, 58699-58708, doi:10.18632/oncotarget.17506 (2017).
14 Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22, 1775-1789, doi:10.1101/gr.132159.111 (2012).
15 Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140, doi:10.1093/bioinformatics/btp616 (2010)
16 Mercer, T. R. & Mattick, J. S. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol 20, 300-307, doi:10.1038/nsmb.2480 (2013).
17 Gibb, E. A., Brown, C. J. & Lam, W. L. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 10, 38, doi:10.1186/1476-4598-10-38 (2011).
18 Li, D. et al. LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a. Mol Ther Nucleic Acids 19, 109-123, doi:10.1016/j.omtn.2019.11.003 (2019).
19 Zhou, M. et al. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma. J Exp Clin Cancer Res 34, 102, doi:10.1186/s13046-015-0219-5 (2015).
20 Li, Z. et al. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme. J Exp Clin Cancer Res 38, 380, doi:10.1186/s13046-019-1371-0 (2019).
21 Han, M. et al. Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/beta-catenin signalling. Brain, doi:10.1093/brain/awz406 (2019).
22 Paw, I., Carpenter, R. C., Watabe, K., Debinski, W. & Lo, H. W. Mechanisms regulating glioma invasion. Cancer Lett 362, 1-7, doi:10.1016/j.canlet.2015.03.015 (2015).
23 Rinn, J. L. et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311-1323, doi:10.1016/j.cell.2007.05.022 (2007).
24 Tan, S. K. et al. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme. Mol Cancer 17, 74, doi:10.1186/s12943-018-0822-0 (2018).
25 Li, L. et al. HOX cluster-embedded antisense long non-coding RNAs in lung cancer. Cancer Lett 450, 14-21, doi:10.1016/j.canlet.2019.02.036 (2019).
26 Lu, W., Xu, Y., Xu, J., Wang, Z. & Ye, G. Identification of differential expressed lncRNAs in human thyroid cancer by a genome-wide analyses. Cancer Med 7, 3935-3944, doi:10.1002/cam4.1627 (2018).
27 Venter, J. C. et al. The sequence of the human genome. Science 291, 1304-1351, doi:10.1126/science.1058040 (2001).
28 Wang, H., Su, H. & Tan, Y. UNC5B-AS1 promoted ovarian cancer progression by regulating the H3K27me on NDRG2 via EZH2. Cell Biol Int, doi:10.1002/cbin.11300 (2020).
29 Cao, Z. et al. Long non-coding RNA UASR1 promotes proliferation and migration of breast cancer cells through the AKT/mTOR pathway. J Cancer 10, 2025-2034, doi:10.7150/jca.29457 (2019).
30 Wang, Y. et al. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines. Hum Cell 32, 334-342, doi:10.1007/s13577-019-00242-8 (2019).
31 Zhang, Y., Li, Z. & Lan, Z. Silencing UNC5B antisense lncRNA 1 represses growth and metastasis of human Colon cancer cells via raising miR-622. Artif Cells Nanomed Biotechnol 48, 60-67, doi:10.1080/21691401.2019.1699809 (2020).